News | September 02, 2023
Jupiter Life Line Hospitals’ IPO to open on Sept. 6
Sets price band at ?695 to ?735 per Equity Share
Sets price band at ?695 to ?735 per Equity Share
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Collaboration combines clinical research expertise with artificial intelligence capabilities to help drug developers better understand the probability of clinical success for their assets
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
Imaginant offers a unique measurement capability through its PELT coating thickness gauges
Subscribe To Our Newsletter & Stay Updated
